LIFECORE BIOMEDICAL INC DE

For the period ended May 28, 2023. Filed Mar 20, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 20, 2024

LFCR$6.37+0.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

ANNUAL REPORT ON FORM 10-K

TABLE OF CONTENTS

Item No.	Description	Page
	Cautionary Note About Forward-Looking Statements	2
Part I
1.	Business	2
1A.	Risk Factors	7
1B.	Unresolved Staff Comments	18
2.	Properties	18
3.	Legal Proceedings	18
4.	Mine Safety Disclosures	18
Part II
5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	19
6.	Selected Financial Data	19
7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19
7A.	Quantitative and Qualitative Disclosures About Market Risk	34
8.	Financial Statements and Supplementary Data	35
9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	35
9A.	Controls and Procedures	35
9B.	Other Information	37
9C.	Disclosure Regarding Jurisdictions that Prevent Inspections	37
Part III
10.	Directors, Executive Officers and Corporate Governance	38
11.	Executive Compensation	43
12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	60
13.	Certain Relationships and Related Transactions, and Director Independence	63
14.	Principal Accountant Fees and Services	65
Part IV
15.	Exhibits and Financial Statement Schedules	66
	Signatures	243

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.

About this filing

Table of Contents